Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...

Response is also considering running trials of the weight management drug RDX-002 in combination with GLP-1RA therapies.

Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...

DARPA has developed a radio frequency test range to refine to help the US simulate complex RF engagements for modern EW ...

Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...

PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

As cyber attacks on major retailers like Pandora continue to hit headlines, experts are urging ecommerce businesses to step ...

Survey suggests power infrastructure is the biggest barrier to investing in battery-electric vehicles (BEVs) in mining.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

Greater China emerges as key player, driven by Hong Kong’s resurgence and "shifting global capital flows toward Chinese ...